Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Signorelli

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 19, 2025
Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysisMatteo Secchi, Mauro Signorelli, Eliana Rulli, et al.
Cancer Research|April 5, 2005
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine productionPaola Allavena, Mauro Signorelli, Marcello Chieppa, et al.
Oncology|June 20, 2018
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?Domenica Lorusso, Fabio Martinelli, Giuseppa Maltese, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 7, 2018
Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar JunctionGiorgio Bogani, Francesca Taverna, Claudia Lombardo, et al.
Journal of Minimally Invasive Gynecology|June 27, 2017
Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy"Giorgio Bogani, Mauro Signorelli, Valentina Chiappa, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 27, 2016
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancerGiorgio Bogani, Ilaria Sabatucci, Giuseppa Maltese, et al.
Gynecologic Oncology|August 7, 2017
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGiorgio Bogani, Elena Tagliabue, Antonino Ditto, et al.
Journal of Minimally Invasive Gynecology|February 23, 2017
Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysisGiorgio Bogani, Chiara Borghi, Umberto Leone Roberti Maggiore, et al.
Journal of Minimally Invasive Gynecology|March 29, 2017
Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer StagingGiorgio Bogani, Chiara Borghi, Antonino Ditto, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|November 19, 2025
Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysisMatteo Secchi, Mauro Signorelli, Eliana Rulli, et al.
Cancer Research|April 5, 2005
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine productionPaola Allavena, Mauro Signorelli, Marcello Chieppa, et al.
Oncology|June 20, 2018
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?Domenica Lorusso, Fabio Martinelli, Giuseppa Maltese, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 7, 2018
Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar JunctionGiorgio Bogani, Francesca Taverna, Claudia Lombardo, et al.
Journal of Minimally Invasive Gynecology|June 27, 2017
Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy"Giorgio Bogani, Mauro Signorelli, Valentina Chiappa, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 27, 2016
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancerGiorgio Bogani, Ilaria Sabatucci, Giuseppa Maltese, et al.
Gynecologic Oncology|August 7, 2017
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGiorgio Bogani, Elena Tagliabue, Antonino Ditto, et al.
Journal of Minimally Invasive Gynecology|February 23, 2017
Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysisGiorgio Bogani, Chiara Borghi, Umberto Leone Roberti Maggiore, et al.
Journal of Minimally Invasive Gynecology|March 29, 2017
Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer StagingGiorgio Bogani, Chiara Borghi, Antonino Ditto, et al.
Pageof 11